Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.AuthorsWalling, David; Marder, Stephen R.; Kane, John; Fleischhacker, W. Wolfgang; Keefe, Richard S. E.; Hosford, David A.; Dvergsten, Chris; Segreti, Anthony C.; Beaver, Jessica S.; Toler, Steven M.; Jett, John E.; Dunbar, Geoffrey C.PublicationSchizophrenia Bulletin, 2016, Vol 42, Issue 2, p335ISSN0586-7614Publication typeArticleDOI10.1093/schbul/sbv072